1 |
35398086 |
10.1016/j.envres.2022.113245 |
2022 |
Molecular docking and optical sensor studies based on 2,4-diamino pyrimidine-5-carbonitriles for detection of Hg<sup>2</sup>. |
WEE1 |
2 |
35578798 |
10.1002/jcp.30777 |
2022 |
Neddylation inactivation affects cell cycle and apoptosis in sheep follicular granulosa cells. |
WEE1 |
3 |
31919076 |
10.3324/haematol.2019.231126 |
2021 |
WEE1 inhibition induces glutamine addiction in T-cell acute lymphoblastic leukemia. |
WEE1 |
4 |
33414171 |
10.1158/0008-5472.CAN-20-1504 |
2021 |
CDK2-Mediated Upregulation of TNFα as a Mechanism of Selective Cytotoxicity in Acute Leukemia. |
WEE1 |
5 |
34390915 |
10.1016/j.dnarep.2021.103203 |
2021 |
Targeting Wee1 kinase as a therapeutic approach in Hematological Malignancies. |
WEE1 |
6 |
32010435 |
10.1177/2040620719898373 |
2020 |
WEE1 inhibition synergizes with CHOP chemotherapy and radiation therapy through induction of premature mitotic entry and DNA damage in diffuse large B-cell lymphoma. |
WEE1 |
7 |
32314355 |
10.1111/bjh.16614 |
2020 |
The Wee1 kinase inhibitor MK1775 suppresses cell growth, attenuates stemness and synergises with bortezomib in multiple myeloma. |
WEE1 |
8 |
32601814 |
10.1007/s11864-020-00763-7 |
2020 |
Targeting DNA Damage Repair Pathways in Pancreatic Adenocarcinoma. |
WEE1 |
9 |
32892059 |
10.1016/j.ctrv.2020.102090 |
2020 |
Targeting the DNA damage response for patients with lymphoma: Preclinical and clinical evidences. |
WEE1 |
10 |
33374413 |
10.3390/ijms22010122 |
2020 |
Tracking the Genetic Susceptibility Background of B-Cell Non-Hodgkin's Lymphomas from Genome-Wide Association Studies. |
WEE1 |
11 |
30601995 |
10.1093/jn/nxy224 |
2019 |
Treatment with DHA Modifies the Response of MDA-MB-231 Breast Cancer Cells and Tumors from nu/nu Mice to Doxorubicin through Apoptosis and Cell Cycle Arrest. |
WEE1 |
12 |
30967394 |
10.1182/bloodadvances.2018029660 |
2019 |
MicroRNA-155 controls vincristine sensitivity and predicts superior clinical outcome in diffuse large B-cell lymphoma. |
WEE1 |
13 |
31064869 |
10.1158/1535-7163.MCT-18-0919 |
2019 |
DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas. |
WEE1 |
14 |
31123088 |
10.1158/0008-5472.CAN-18-2480 |
2019 |
Differential Activity of ATR and WEE1 Inhibitors in a Highly Sensitive Subpopulation of DLBCL Linked to Replication Stress. |
WEE1 |
15 |
31341363 |
10.3748/wjg.v25.i26.3380 |
2019 |
Raddeanin A promotes apoptosis and ameliorates 5-fluorouracil resistance in cholangiocarcinoma cells. |
WEE1 |
16 |
31590241 |
10.3390/cancers11101494 |
2019 |
Isorhamnetin Induces Cell Cycle Arrest and Apoptosis Via Reactive Oxygen Species-Mediated AMP-Activated Protein Kinase Signaling Pathway Activation in Human Bladder Cancer Cells. |
WEE1 |
17 |
31703356 |
10.3390/cancers11111743 |
2019 |
WEE1 Inhibition Enhances Anti-Apoptotic Dependency as a Result of Premature Mitotic Entry and DNA Damage. |
WEE1 |
18 |
28025833 |
10.1111/bjh.14506 |
2018 |
Inhibition of CHK1 and WEE1 as a new therapeutic approach in diffuse large B cell lymphomas with MYC deregulation. |
WEE1 |
19 |
29175378 |
10.1016/j.leukres.2017.11.004 |
2018 |
Increased activity of both CDK1 and CDK2 is necessary for the combinatorial activity of WEE1 inhibition and cytarabine. |
WEE1 |
20 |
29217775 |
10.3324/haematol.2017.175992 |
2018 |
Chemotherapy-induced differential cell cycle arrest in B-cell lymphomas affects their sensitivity to Wee1 inhibition. |
WEE1 |
21 |
29367434 |
10.1074/mcp.RA117.000539 |
2018 |
Proteomics Profiling of CLL Versus Healthy B-cells Identifies Putative Therapeutic Targets and a Subtype-independent Signature of Spliceosome Dysregulation. |
WEE1 |
22 |
29489886 |
10.1371/journal.pone.0193098 |
2018 |
Identification of relevant drugable targets in diffuse large B-cell lymphoma using a genome-wide unbiased CD20 guilt-by association approach. |
WEE1 |
23 |
29617859 |
10.1093/femspd/fty013 |
2018 |
Human lung epithelial cells support human metapneumovirus persistence by overcoming apoptosis. |
WEE1 |
24 |
30068368 |
10.1186/s13045-018-0641-1 |
2018 |
Targeting WEE1 to enhance conventional therapies for acute lymphoblastic leukemia. |
WEE1 |
25 |
27072241 |
10.4103/0973-1482.165861 |
2016 |
Tumour suppressive effects of WEE1 gene silencing in neuroblastomas. |
WEE1 |
26 |
25428911 |
10.18632/oncotarget.2583 |
2015 |
Combined inhibition of Chk1 and Wee1 as a new therapeutic strategy for mantle cell lymphoma. |
WEE1 |
27 |
25594541 |
10.1667/RR13784.1 |
2015 |
The miR-15 family enhances the radiosensitivity of breast cancer cells by targeting G2 checkpoints. |
WEE1 |
28 |
25744022 |
10.1038/cdd.2015.13 |
2015 |
The Fcp1-Wee1-Cdk1 axis affects spindle assembly checkpoint robustness and sensitivity to antimicrotubule cancer drugs. |
WEE1 |
29 |
26334102 |
10.18632/oncotarget.4830 |
2015 |
AZD1775 sensitizes T cell acute lymphoblastic leukemia cells to cytarabine by promoting apoptosis over DNA repair. |
WEE1 |
30 |
26439697 |
10.18632/oncotarget.5954 |
2015 |
Characterization of a mantle cell lymphoma cell line resistant to the Chk1 inhibitor PF-00477736. |
WEE1 |
31 |
22333592 |
10.4161/cc.11.5.19519 |
2012 |
Antitumor activity of new pyrazolo[3,4-d]pyrimidine SRC kinase inhibitors in Burkitt lymphoma cell lines and its enhancement by WEE1 inhibition. |
WEE1 |
32 |
18416826 |
10.1186/1471-2407-8-106 |
2008 |
Explorative data analysis of MCL reveals gene expression networks implicated in survival and prognosis supported by explorative CGH analysis. |
WEE1 |
33 |
12406077 |
10.1046/j.1365-2141.2002.03834.x |
2002 |
Monensin-mediated growth inhibition in human lymphoma cells through cell cycle arrest and apoptosis. |
WEE1 |
34 |
9699647 |
|
1998 |
Negative regulation of Wee1 expression and Cdc2 phosphorylation during p53-mediated growth arrest and apoptosis. |
WEE1 |
35 |
8833397 |
10.3109/10428199609052423 |
1996 |
Role of tyrosine phosphorylation in radiation-induced cell cycle-arrest of leukemic B-cell precursors at the G2-M transition checkpoint. |
WEE1 |
36 |
7531277 |
10.1007/BF00926071 |
1994 |
Changes of cell cycle-regulating genes in interferon-treated Daudi cells. |
WEE1 |